MedTrace Logo

Closing the Loop in Adults With Type 1 Diabetes - Alcohol Consumption

NCT00944619 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2010-05-12

No results posted yet for this study

Summary

The main objective is to assess the efficacy and safety of overnight automated closed loop glucose control using a computer-based algorithm compared with conventional insulin pump therapy in adults with type 1 diabetes following the consumption of a moderate amount of alcohol at dinnertime.

Conditions

Interventions

DEVICE

Closed loop

Subcutaneous delivery of Novorapid insulin, dose calculated by control algorithm, based on continuous glucose sensor readings

DEVICE

Conventional insulin pump delivery

Subcutaneous delivery of Novorapid insulin according to usual pump regime

Sponsors & Collaborators

Principal Investigators

  • Mark L Evans, MD FRCP · University of Cambridge, UK

  • Roman Hovorka, PhD · University of Cambridge, UK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00944619 on ClinicalTrials.gov